文献速递儿童青少年精神焦虑、强迫与应激相关障碍

威胁相关神经效率降低:儿童焦虑障碍的潜在生物标志物

Reduced Threat-Related Neural Efficiency: A Possible Biomarker for Pediatric Anxiety Disorders.
PubMed 文献 · Am J Psychiatry · 2025-10-08

该研究比较了103名焦虑障碍青少年与103名无精神科诊断青少年,用功能磁共振计算全脑内在功能连接与威胁任务功能连接的偏相关作为神经效率。神经效率与焦虑诊断及症状维度负相关,基线较低者暴露式认知行为治疗反应更差。

要点

  • 神经效率在健康青少年11至18周重测信度尚可(ICC=0.65)。
  • 神经效率与焦虑诊断类别(t=2.62,d=0.29)及症状维度(r=-0.18)显著负相关。
  • 基线神经效率越低,80名接受认知行为治疗青少年的治疗反应越差(β=-11.88,χ2=9.20)。

核心结论

  • 以静息与任务间网络重构测量的神经效率,有望成为儿童焦虑障碍的生物标志物。
  • 神经效率与认知行为治疗反应相关,可能有助于患者分层并作为增强疗效的干预靶点。

研究设计与样本

  • 研究比较103名焦虑障碍青少年(平均年龄12.5岁,SD=2.91,62%女性)与103名无精神科诊断青少年(平均年龄13.4岁,SD=2.58,53%女性)。
  • 参与者在静息状态及威胁面孔点探测任务中完成功能磁共振,神经效率以全脑内在功能连接与任务相关功能连接模式的偏相关计算。
  • 研究检验了4个月重测信度、神经效率与焦虑的关系,以及在80名接受暴露式认知行为治疗焦虑青少年中与治疗反应的关系。

主要发现

  • 神经效率在健康青少年11至18周期间显示满意的重测信度(组内相关系数=0.65)。
  • 神经效率与焦虑诊断类别显著负相关(t=2.62,d=0.29),与焦虑症状维度也显著负相关(r=-0.18)。
  • 认知行为治疗后神经效率未发生变化,但基线神经效率较低与80名接受认知行为治疗焦虑青少年中较差的治疗反应显著相关(β=-11.88,χ2=9.20)。

临床怎么用

  • 神经效率可作为儿童焦虑障碍的潜在生物标志物,辅助识别治疗反应可能较差的青少年。
  • 基线神经效率较低者接受暴露式认知行为治疗反应较差,提示可考虑分层干预或增强疗效的策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Pediatric anxiety disorders are common and predict adult psychopathology, yet current treatments, such as cognitive-behavioral therapy (CBT), produce lasting remission in less than 50% of affected youths. To support the search for improved, mechanistically grounded interventions, this study evaluated neural efficiency, defined as similarity in functional connectivity between a threat task and rest, as a potential biomarker. The study evaluated neural efficiency in relation to anxiety diagnosis and treatment response. METHODS: The authors compared 103 youths with an anxiety disorder diagnosis (mean age, 12.5 years [SD=2.91], 62% female) to 103 youths with no psychiatric diagnosis (mean age, 13.4 years [SD=2.58], 53% female). Participants completed functional MRI while resting and during a dot-probe task with threatening faces. Neural efficiency was calculated as partial correlations between intrinsic and task-related functional connectivity patterns across the whole brain. Four-month test-retest reliability as well as relationships with anxiety and response to exposure-based CBT were examined. RESULTS: Neural efficiency demonstrated satisfactory test-retest reliability (intraclass correlation coefficient=0.65) in healthy youths over a period of 11 to 18 weeks. Neural efficiency was significantly negatively related to anxiety as both a diagnostic category (t=2.62, d=0.29) and a symptom dimension (r=-0.18). Although it did not change after CBT, lower neural efficiency at baseline was significantly associated with poorer treatment response in a subset of 80 anxious youths who underwent CBT (β=-11.88, χ2=9.20). CONCLUSIONS: Neural efficiency, measured as network reconfiguration between rest and task, holds promise as a biomarker in pediatric anxiety. Its association with CBT response suggests that it might aid in patient stratification and offer a target for interventions aimed at enhancing CBT efficacy.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Linke JO, Naim R, Haller SP, et al. Reduced Threat-Related Neural Efficiency: A Possible Biomarker for Pediatric Anxiety Disorders. Am J Psychiatry. 2025. PMID: 41058235. doi:10.1176/appi.ajp.20241043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。